Retrieve available abstracts of 83 articles: HTML format
Single Articles
July 2025
ZHAO T, Hung YP, Devins KM, Young RH, et al The Spectrum of Vascular Lesions of the Upper Female Genital Tract: A Report of
55 Cases.
Int J Gynecol Pathol. 2025;44:291-307. PubMedAbstract available
ABBASI F, Nucci MR, Doron B, Ruskin R, et al Case Report: ESR1::CITED2 Fusion in a Malignant Uterine Tumor Resembling Ovarian
Sex Cord Tumor.
Int J Gynecol Pathol. 2025;44:368-373. PubMedAbstract available
NISHIJIMA Y, Inoue N, Iwase A, Ikota H, et al Lamin A and Emerin Protein Expression Remains Consistently Low and Nuclear Size
is Unchanged in Normal Endometrium, Precancerous Lesions, and Endometrioid
Carcinoma.
Int J Gynecol Pathol. 2025;44:340-348. PubMedAbstract available
NEMEJCOVA K, Safanda A, Kendall Bartu M, Hajkova N, et al HER2 Status in Low-grade Serous Ovarian Tumors.
Int J Gynecol Pathol. 2025;44:331-335. PubMedAbstract available
May 2025
JO U Adenomatoid Tumor Mimicking Peritoneal Carcinomatosis: A Case Report.
Int J Gynecol Pathol. 2025;44:286-290. PubMedAbstract available
CARLSON DK, Painter C, Gradecki SE, Ring KL, et al High-grade Endometrial Carcinomas With Solid Basaloid Morphology and Geographic
Necrosis Lacking Definitive Pilomatrix-like Features: Clinicopathologic
Characteristics Including Aggressive Behavior and Novel Molecular Events.
Int J Gynecol Pathol. 2025;44:199-209. PubMedAbstract available
MASAADEH AH, Dundar B, Samuelson MI, Kadera E, et al Bilateral Somatically Derived Germ Cell Tumors With 12p Gains Arising in
High-grade Serous Carcinomas of the Ovary: A Case Report and Review of the
Literature.
Int J Gynecol Pathol. 2025;44:258-264. PubMedAbstract available
YAMAGATA T, Watanabe K, Yamanoi K, Kakiuchi N, et al Origin of Peritoneal Cancer With Features of High-grade Serous Carcinoma: A
Detailed Molecular Analysis.
Int J Gynecol Pathol. 2025;44:280-285. PubMedAbstract available
GULSEREN V, Sen E, Dolanbay M, Cagli F, et al Association of Local and Distant Organ Metastases With MELF Pattern in
Endometrial Cancer.
Int J Gynecol Pathol. 2025;44:237-241. PubMedAbstract available
JAMES E, Ravikumar G, Michael Raj A J, Kulkarni K, et al Prognostic Significance of "High" Tumor Budding and "High" Poorly Differentiated
Clusters in Endometrial Carcinomas: Independent Predictors of Lymphovascular
Space Invasion and Lymph Node Metastasis.
Int J Gynecol Pathol. 2025;44:222-229. PubMedAbstract available
YOO YJ, Kim YJ, Kim YM, Kim KR, et al The Prognostic Value of Tumor Cell Clusters in the Fallopian Tube Lumen in Stage
I Endometrioid Carcinoma.
Int J Gynecol Pathol. 2025;44:242-248. PubMedAbstract available
March 2025
TURASHVILI G, Hanley K Malignant Brenner Tumor of the Ovary: A Critical Reappraisal.
Int J Gynecol Pathol. 2025;44:182-192. PubMedAbstract available
MAHARJAN D, Collins K, Hou T, Umphress B, et al Synchronous Bilateral Ovarian Carcinomas With Right Mesonephric-like
Adenocarcinoma and Left High-grade Serous Carcinoma: A Case Report and Review of
the Literature.
Int J Gynecol Pathol. 2025;44:193-197. PubMedAbstract available
LAWSON BC, Marques-Piubelli ML, Westin SN, Malpica A, et al Folate Receptor Immunohistochemical Staining and Gynecologic Tumors: Initial
Experience With 216 Cases.
Int J Gynecol Pathol. 2025;44:167-173. PubMedAbstract available
ZHAO X, Song Z, Liu Y, Zheng X, et al Synchronous Endometrial and Ovarian Endometrioid Carcinoma With MUTYH Germline
Mutation: A Case Report With Genetic Analysis.
Int J Gynecol Pathol. 2025;44:155-159. PubMedAbstract available
January 2025
CHRISTENSEN D, Ghafoor M, Goldberg A, De Cotiis DA, et al Tumor Budding, Poorly Differentiated Clusters, and Stroma Percentage in Uterine
Endometrioid Carcinomas Are Morphologic Findings Associated With Adverse Clinical
Outcomes.
Int J Gynecol Pathol. 2025;44:49-55. PubMedAbstract available
DEL MUNDO MM, Aguilar M, Chen H, Niu S, et al beta-catenin, PAX2, and PTEN Aberrancy Across the Spectrum of Endometrioid Ovarian
Lesions.
Int J Gynecol Pathol. 2025;44:79-87. PubMedAbstract available
DE BOECK A, Nohr E, El-Hallani S, Ghatage P, et al POLE-mutated Endometrial "Carcinosarcoma".
Int J Gynecol Pathol. 2025;44:72-78. PubMedAbstract available
WANG L, Vasudevaraja V, Tran I, Sukhadia P, et al Novel Androgen Receptor Splice Variant 7 in Gynecologic Tumors.
Int J Gynecol Pathol. 2025;44:88-93. PubMedAbstract available
November 2024
DA-ANOY A, Kang EY, Lee CH, Cheasley D, et al Molecular Surrogate Subtypes of Ovarian and Peritoneal Low-grade Serous
Carcinoma.
Int J Gynecol Pathol. 2024;43:617-625. PubMedAbstract available
BUI CM, Azimpouran M, Balzer B, Maluf H, et al Stromal p16 and SATB2 Expression Does Not Distinguish Atypical Polypoid
Adenomyoma (APA) From its Benign Mimics.
Int J Gynecol Pathol. 2024;43:586-594. PubMedAbstract available
NOVIKOV FV, Anufriev AG, Efremov GD High-grade Serous Carcinoma Occurring in a Serous Cystadenoma on the Background
of a Serous Tubal Intraepithelial Carcinoma (STIC)-like Lesion: A Case Report
With Literature Review.
Int J Gynecol Pathol. 2024;43:626-630. PubMedAbstract available
NAGY A, Niu N, Ratner E, Hui P, et al Novel FOXL2 Mutation in an Ovarian Adult Granulosa Cell Tumor: Report of a Case
With Diagnostic and Clinicopathologic Implications.
Int J Gynecol Pathol. 2024;43:631-636. PubMedAbstract available
FUKUMITSU C, Sanada S, Ogasawara S, Tsuda N, et al CXCR4 Expression and Cancer-associated Fibroblasts May Play an Important Role in
the Invasion of Low-grade Endometrioid Carcinoma.
Int J Gynecol Pathol. 2024;43:557-564. PubMedAbstract available
HACHISUGA K, Kawakami M, Tomonobe H, Maenohara S, et al Clinical Significance of Tumor Immune Microenvironment in Endometrial
Endometrioid Carcinoma, Grade 1 With DNA Mismatch Repair Protein Loss.
Int J Gynecol Pathol. 2024;43:573-585. PubMedAbstract available
September 2024
VAZIRI FARD E, Imboden S, Rau T, Epstein E, et al p53 Abnormal (Copy Number High) Endometrioid Endometrial Carcinoma Has a
Prognosis Indistinguishable From Serous Carcinoma.
Int J Gynecol Pathol. 2024;43:515-526. PubMedAbstract available
MOH M, Puzyrenko A, Summey R, Rader JS, et al Clinicopathologic Characteristics of a Single-institution Cohort of Ovarian Adult
Granulosa Cell Tumors, With Biomarker and Therapeutic Implications Utilizing the
Detection of Androgen, Estrogen, and Progesterone Hormone Receptor Expression by
Immunoh
Int J Gynecol Pathol. 2024;43:527-534. PubMedAbstract available
HUVILA J, Jamieson A, Pors J, Hoang L, et al Endometrial Carcinosarcomas are Almost Exclusively of p53abn Molecular Subtype
After Exclusion of Mimics.
Int J Gynecol Pathol. 2024;43:506-514. PubMedAbstract available
LIU N, Lin W, Wang Y, Yao Z, et al Predicting Progestin Therapy Response With PTEN, PAX2, and beta-Catenin in Patients
With Endometrioid Precancer.
Int J Gynecol Pathol. 2024;43:494-505. PubMedAbstract available
July 2024
MIYAMA Y, Ogasawara A, Hasegawa K, Yasuda M, et al Premature Classification of Early-stage Endometrioid Ovarian Carcinoma With
Mesonephric-like Differentiation as Mesonephric-like Adenocarcinoma.
Int J Gynecol Pathol. 2024;43:362-372. PubMedAbstract available
GILMORE B, Logan L, McKinnon W, Everett E, et al Endometrial Cancer in a Family With RAD51D Gene Mutation.
Int J Gynecol Pathol. 2024;43:349-353. PubMedAbstract available
VIKI M, Morrow R Metastatic Hepatocellular Carcinoma Represents an Important but Rare Pitfall in
the Diagnostic Evaluation of ER Negative Ovarian Malignancy: A Case Report.
Int J Gynecol Pathol. 2024;43:378-381. PubMedAbstract available
ZHAO Z, Nadarajah R, Busmanis I Synchronous Bilateral Ovarian Mesonephric-like Adenocarcinomas with Separate
Origins from High-Grade Mullerian Adenosarcoma and Endometriosis: Report of a
Rare Case.
Int J Gynecol Pathol. 2024;43:382-388. PubMedAbstract available
GUERRIERO A, Moro M, Angerilli V, Munari G, et al Synchronous Endometrial and Ovarian Carcinomas: Pathologic and Molecular Analysis
Highlights the Monoclonal Origin of the Lesions.
Int J Gynecol Pathol. 2024;43:309-315. PubMedAbstract available
WANG SC, Wu CH, Fu HC, Ou YC, et al Estrogen/Progesterone Receptor Expression and Cancer Antigen 125 Level as
Preoperative Predictors to Estimate Lymph Node Metastasis in Endometrioid
Endometrial Cancer.
Int J Gynecol Pathol. 2024;43:316-325. PubMedAbstract available
AL-HUSSAINI M, McCluggage WG SATB2 Cytoplasmic Expression is Characteristic of a Subset of Ovarian Stromal
Cells and Sex Cord Stromal Tumors.
Int J Gynecol Pathol. 2024;43:373-377. PubMedAbstract available
June 2024
WALIA A, Ladwig NR, Mak JS, Rabban JT, et al Prevalence of Occult Ovarian Cancer and Metastatic Breast Cancer in Ovarian
Ablation Specimens of Patients With Hormone Receptor-Positive Breast Cancer:
Implications for Tissue Sampling Strategies, Early Ovarian Cancer Detection and
Resource Utilizati
Int J Gynecol Pathol. 2024 Jun 26. doi: 10.1097/PGP.0000000000001055. PubMedAbstract available
May 2024
ALROHAIBANI A, Yu Y, Gao L, McLean KM, et al PReferentially Expressed Antigen in MElanoma Expression in Uterine and Ovarian
Carcinosarcomas.
Int J Gynecol Pathol. 2024;43:284-289. PubMedAbstract available
YAMAMOTO A, Nagai T, Sukeda A, Kajiwara M, et al Ovarian Mesonephric-like Adenocarcinoma Recurring With a Rhabdomyosarcoma
Component: A Case Report.
Int J Gynecol Pathol. 2024;43:296-301. PubMedAbstract available
LI Y, Chen J, Niu S Endometrioid Adenocarcinoma With "Burrowing" Invasion of the Cervix Represents a
Separate Primary From the Concurrent Uterine Corpus Endometrial Endometrioid
Adenocarcinoma: Histology, Immunohistochemistry, and Next-generation Sequencing
Study of a Si
Int J Gynecol Pathol. 2024;43:271-274. PubMedAbstract available
XU J, Weisman PS Divergent Malignant Melanocytic Differentiation in Ovarian Endometrioid
Adenocarcinoma With Aberrant beta-Catenin Expression: A Case Expanding the
Histologic Spectrum of beta-Catenin Activated Gynecologic Neoplasia.
Int J Gynecol Pathol. 2024;43:302-307. PubMedAbstract available
JU B, Wu J, Sun L, Yang C, et al Molecular Classification of Endometrial Endometrioid Carcinoma With Microcystic
Elongated and Fragmented Pattern.
Int J Gynecol Pathol. 2024;43:233-241. PubMedAbstract available
LEE Y, Choi S, Kim HS Comprehensive Immunohistochemical Analysis of Mesonephric Marker Expression in
Low-grade Endometrial Endometrioid Carcinoma.
Int J Gynecol Pathol. 2024;43:221-232. PubMedAbstract available
March 2024
HAN R, Madariaga A, Gonzalez-Ochoa E, Smith AC, et al HER2-low and Overexpression in Mucinous Ovarian Cancer: Analysis of ASCO/CAP and
ToGA Immunohistochemical Scoring.
Int J Gynecol Pathol. 2024 Mar 4. doi: 10.1097/PGP.0000000000000972. PubMedAbstract available
XU J, McGregor SM, Park KJ, Weisman PS, et al Ovarian Endometrioid Adenocarcinomas With Infiltrative "Adenofibroma-like"
Morphology and Aberrant ss-catenin Expression: Tumors That Coexpress CDX2 and LEF1
With Frequent Neuroendocrine Marker Expression, Diminished/Lost PAX8 and Possible
Association
Int J Gynecol Pathol. 2024;43:145-148. PubMed
BHARDWAJ S, Banet N, Gaston EC Moderately-differentiated Ovarian Sertoli-Leydig Cell Tumor With a Concurrent
Serous Borderline Tumor in a 16-year-old Girl.
Int J Gynecol Pathol. 2024;43:140-144. PubMedAbstract available
SMITHGALL MC, Yemelyanova A, Mathew S, Gogineni S, et al HER2/ ERBB2 Immunohistochemical Expression and Copy Number Status in Ovarian
Mucinous Tumors.
Int J Gynecol Pathol. 2024;43:134-139. PubMedAbstract available
KENDALL BARTU M, Nemejcova K, Michalkova R, Bui QH, et al Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors
of the Ovary: A Study of 551 Cases.
Int J Gynecol Pathol. 2024;43:123-133. PubMedAbstract available
KANG EY, Terzic T, Ghatage P, Woo L, et al TP53 as a Diagnostic Aid in the Distinction of Ovarian Mucinous Borderline Tumors
From Mucinous Carcinoma.
Int J Gynecol Pathol. 2024;43:111-122. PubMedAbstract available
January 2024
FISCHER EG Two Rare Cases of Paratubal Leydig Cell Nodules: Clinical Relevance and Debated
Terminology of a Noteworthy Incidentaloma.
Int J Gynecol Pathol. 2024;43:97-101. PubMedAbstract available
ISE K, Tanei ZI, Oda Y, Tanikawa S, et al A Case of Uterine Tumor Resembling Ovarian Sex Cord Tumor With Prominent Myxoid
Features.
Int J Gynecol Pathol. 2024;43:41-46. PubMedAbstract available
WESSMAN S, Fuentes BB, Severin-Karlsson J, Westbom-Fremer S, et al FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by
Morphology.
Int J Gynecol Pathol. 2024;43:78-89. PubMedAbstract available
KAWAGUCHI R, Maehana T, Sugimoto S, Kawahara N, et al Immunohistochemical Analysis of the Tissue Factor Pathway Inhibitor-2 in
Endometrial Clear Cell Carcinoma: A Single-center Retrospective Study.
Int J Gynecol Pathol. 2024;43:25-32. PubMedAbstract available
XU J, Park KJ, Weisman PS An Expanded Series of Pilomatrix-like High-grade Endometrioid Carcinoma (PiMHEC),
Including Both MMR Deficient and MMR Proficient Cases.
Int J Gynecol Pathol. 2024;43:67-69. PubMed
ELMUTI L, Amundson J, Oberman E, Kamat A, et al Diffuse Pediatric-type High-grade Glioma Arising in an Ovarian Mature Cystic
Teratoma.
Int J Gynecol Pathol. 2024;43:90-96. PubMedAbstract available
WEPY C, Nucci MR, Parra-Herran C Atypical Endometriosis: Comprehensive Characterization of Clinicopathologic,
Immunohistochemical, and Molecular Features.
Int J Gynecol Pathol. 2024;43:70-77. PubMedAbstract available
November 2023
YOSHINO Y, Yanai S, Sawada M, Sakate S, et al Extraovarian Dysgerminoma Involving the Uterine Cervix: A Rare Case Report With
Literature Review.
Int J Gynecol Pathol. 2023;42:544-549. PubMedAbstract available
MATSUMOTO N, Manrai P, Rottmann D, Wu X, et al Correlative Assessment of p53 Immunostaining Patterns and TP53 Mutation Status by
Next-Generation Sequencing in High-Grade Endometrial Carcinomas.
Int J Gynecol Pathol. 2023;42:567-575. PubMedAbstract available
ALNA'IRAT M, McCluggage WG, Al-Hussaini M Ovarian Immature Teratoma With Nodal Gliomatosis: A Case Report and Literature
Review.
Int J Gynecol Pathol. 2023;42:627-631. PubMedAbstract available
STOLNICU S, Bartalis RJ, Ye Q, Da Cruz Paula A, et al Ovarian RASoma With Mesonephric-like Adenocarcinoma and Mixed Mullerian
Components: A Case Report With Molecular Analysis Demonstrating Multidirectional
Mullerian Differentiation.
Int J Gynecol Pathol. 2023;42:620-626. PubMedAbstract available
LIN LH, Zamuco RD, Shukla PS Ovarian Clear Cell Carcinoma and Markers of Epithelial-Mesenchymal Transition
(EMT): Immunohistochemical Characterization of Tumor Budding.
Int J Gynecol Pathol. 2023;42:602-612. PubMedAbstract available
October 2023
BICER E, Bese T, Tuzun DD, Ilvan S, et al The Relationship Between Melatonin 1-2 Receptor Expression in Patients With
Epithelial Ovarian Cancer and Survival.
Int J Gynecol Pathol. 2023 Oct 4. doi: 10.1097/PGP.0000000000000968. PubMedAbstract available
September 2023
KEANE E, Floyd R, McDonnell C, Beirne JP, et al Endometrioid Adenocarcinoma Resembling Cutaneous Pilomatrix Carcinoma: A Case
Report of an Aggressive Neoplasm in a Young Woman With Diffusely Aberrant
Beta-catenin Expression and Associated Morular Metaplasia and Atypical Polypoid
Adenomyoma-type Cha
Int J Gynecol Pathol. 2023;42:466-471. PubMedAbstract available
DYHDALO KS, Ababneh E, Lanigan C, Bowers K, et al Evaluation of Lineage/Site-specific Nuclear Immunohistochemical Markers SATB2,
Cyclin D1, SALL4, and BCOR in High-grade Endometrial Carcinomas.
Int J Gynecol Pathol. 2023;42:443-450. PubMedAbstract available
KEYHANIAN K, Yang EJ, Howitt BE Nuclear beta-Catenin Expression in the Context of Abnormal p53 Expression Indicates
a Nonserous Histotype in Endometrial Carcinoma.
Int J Gynecol Pathol. 2023;42:435-442. PubMedAbstract available
TALIA KL, Ratnayake G, McCluggage WG Microscopic Sertoliform Sex Cord Proliferation Involving Pelvic Peritoneum:
Report of a Case Associated With Endosalpingiosis.
Int J Gynecol Pathol. 2023;42:496-499. PubMedAbstract available
DONTHI D, Chen H, Peng Y, Niu S, et al Ovarian Microcystic Stromal Tumor With Intraovarian Recurrence and Peritoneal and
Omental Spread: A Case Report With Morphological, Immunohistochemical, and
Molecular Analysis.
Int J Gynecol Pathol. 2023;42:491-495. PubMedAbstract available
CHIESA-VOTTERO AG Ovarian Mucinous Borderline Tumor With Intraepithelial Carcinoma.
Int J Gynecol Pathol. 2023;42:514. PubMed
GUERRIERI C, Hudacko R, Anderson P Composite FOXL2 Mutation-positive Adult Granulosa Cell Tumor and Serous
Borderline Tumor of the Ovary.
Int J Gynecol Pathol. 2023;42:500-507. PubMedAbstract available
CHUI MH, Murali R, Soslow RA, Matrai C, et al Interobserver Reproducibility in Assessing Eosinophilic Cells in Ovarian Serous
Borderline Tumors to Predict BRAF Mutational Status.
Int J Gynecol Pathol. 2023;42:472-481. PubMedAbstract available
ANDRADE LALA, Alame M, Truffaux N, Croce S, et al Adult Granulosa Cell Tumour With Heterologous Adipocytic Differentiation: Report
of a Unique Case.
Int J Gynecol Pathol. 2023;42:508-513. PubMedAbstract available
July 2023
CHUI MH, Grisham RN Somatic BAP1 Loss in Ovarian Serous Borderline Tumor and Recurrent Low-grade
Serous Carcinoma From a Germline BAP1 Mutation Carrier.
Int J Gynecol Pathol. 2023;42:432-433. PubMed
TALHOUK A, Jamieson A, Crosbie EJ, Taylor A, et al Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically
Driven Selective ProMisE Testing Protocol.
Int J Gynecol Pathol. 2023;42:353-363. PubMedAbstract available
BRAUN A, Reddy S, Cheng L, Gattuso P, et al Clinicopathologic Review of Metastatic Breast Cancer to the Gynecologic Tract.
Int J Gynecol Pathol. 2023;42:414-420. PubMedAbstract available
HALL KC, Post MD, Alldredge J, Aisner DL, et al Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell
Neoplasms: Report of 2 Cases and Review of Literature.
Int J Gynecol Pathol. 2023;42:403-413. PubMedAbstract available
KOSTELECKY N, Ozhegov E, Cao D, Krigman H, et al Metastatic Cholangiocarcinoma to the Uterus Morphologically Imitating Primary
Intestinal-type Endometrioid Adenocarcinoma.
Int J Gynecol Pathol. 2023;42:398-402. PubMedAbstract available
LAU JCC, McCluggage WG, Yuen LYP, Shing MMK, et al DICER1 -Altered Extraovarian Moderately Differentiated Sertoli-Leydig Cell Tumor:
Report of a Rare Case.
Int J Gynecol Pathol. 2023;42:421-425. PubMedAbstract available
SUN Y, Liu-Jarin X, Hamele-Bena D, Murty VV, et al Ovarian Malignant Mixed Germ Cell Tumor With Prominent Embryoid Bodies
(Polyembryoma Background): A Case Report and Literature Review.
Int J Gynecol Pathol. 2023;42:426-431. PubMedAbstract available
May 2023
STRICKLAND AL, Maniar KP, Tanner E, Shanes E, et al Borderline With Bad Behavior: An Unusual Low-grade Serous Carcinoma With
Dedifferentiation From a Serous Borderline Tumor.
Int J Gynecol Pathol. 2023;42:241-246. PubMedAbstract available
YOSHIDA H, Uno M, Ogimoto K, Kobayashi-Kato M, et al Endometrioid Endometrial Carcinoma With NKX3.1 Expression in a Transgender Man: A
Case Report.
Int J Gynecol Pathol. 2023;42:308-314. PubMedAbstract available
OMO-OGBOI AC, Deavers MT, Schmeler KM, Tandon N, et al Collision Tumor of the Ovary Involving Sertoli-Leydig Cell Tumor and High-Grade
Serous Carcinoma-Report of the First Case.
Int J Gynecol Pathol. 2023;42:254-258. PubMedAbstract available
MENDOZA R, Kertowidjojo E CTNNB1 -mutated High-grade Endometrioid Carcinoma With Extensive Squamous and
Shadow Cell Differentiation Can Mimic Pilomatrix Carcinoma.
Int J Gynecol Pathol. 2023;42:325-326. PubMed
HALLING GC, Udager AM, Skala SL Endometrial, Ovarian, and Peritoneal Involvement by Endometrioid Carcinoma, Yolk
Sac Tumor, and Endometriosis: Molecular Evidence for a Shared Precursor.
Int J Gynecol Pathol. 2023;42:247-253. PubMedAbstract available